221 related articles for article (PubMed ID: 28318807)
21. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Therapeutic Success of MicroRNA-155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage.
Zhou S; Wang Y; Meng Y; Xiao C; Liu Z; Brohawn P; Higgs BW; Jallal B; Jia Q; Qu B; Huang X; Tang Y; Yao Y; Harley JB; Shen N
Arthritis Rheumatol; 2016 Apr; 68(4):953-64. PubMed ID: 26556607
[TBL] [Abstract][Full Text] [Related]
23. 17β-Estradiol enhances the activation of IFN-α signaling in B cells by down-regulating the expression of let-7e-5p, miR-98-5p and miR-145a-5p that target IKKε.
Dong G; Fan H; Yang Y; Zhao G; You M; Wang T; Hou Y
Biochim Biophys Acta; 2015 Aug; 1852(8):1585-98. PubMed ID: 25912736
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
Liu J; Berthier CC; Kahlenberg JM
Arthritis Rheumatol; 2017 Sep; 69(9):1840-1849. PubMed ID: 28564495
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
Front Immunol; 2021; 12():747616. PubMed ID: 34745118
[TBL] [Abstract][Full Text] [Related]
26. α-Ketoglutarate-Dependent KDM6 Histone Demethylases and Interferon-Stimulated Gene Expression in Lupus.
Montano EN; Bose M; Huo L; Tumurkhuu G; De Los Santos G; Simental B; Stotland AB; Wei J; Bairey Merz CN; Suda J; Martins G; Lalani S; Lawrenson K; Wang Y; Parker S; Venuturupalli S; Ishimori M; Wallace DJ; Jefferies CA
Arthritis Rheumatol; 2024 Mar; 76(3):396-410. PubMed ID: 37800478
[TBL] [Abstract][Full Text] [Related]
27. The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.
Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Baumgrass R; Stuhlmüller B; Maslinski W; Hiepe F; Burmester GR; Radbruch A; Häupl T; Grützkau A
J Mol Med (Berl); 2012 Nov; 90(11):1295-309. PubMed ID: 22610275
[TBL] [Abstract][Full Text] [Related]
28. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.
Kato Y; Park J; Takamatsu H; Konaka H; Aoki W; Aburaya S; Ueda M; Nishide M; Koyama S; Hayama Y; Kinehara Y; Hirano T; Shima Y; Narazaki M; Kumanogoh A
Ann Rheum Dis; 2018 Oct; 77(10):1507-1515. PubMed ID: 29945921
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in the key events of systemic lupus erythematosus pathogenesis.
Husakova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):327-42. PubMed ID: 27003314
[TBL] [Abstract][Full Text] [Related]
31. Subcellular localization and functional characterization of a fish IRF9 from crucian carp Carassius auratus.
Shi J; Zhang YB; Liu TK; Sun F; Gui JF
Fish Shellfish Immunol; 2012 Aug; 33(2):258-66. PubMed ID: 22626811
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of interferon regulatory factor 9 (IRF9).
Paul A; Ismail MN; Tang TH; Ng SK
Mol Biol Rep; 2023 Apr; 50(4):3909-3917. PubMed ID: 36662450
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs in the pathogenesis of systemic lupus erythematosus.
Ma X; Liu Q
Int J Rheum Dis; 2013 Apr; 16(2):115-21. PubMed ID: 23773633
[TBL] [Abstract][Full Text] [Related]
34. Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data.
Yao M; Zhang C; Gao C; Wang Q; Dai M; Yue R; Sun W; Liang W; Zheng Z
Front Immunol; 2021; 12():658341. PubMed ID: 34335565
[TBL] [Abstract][Full Text] [Related]
35. Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients.
Sarhan RA; Aboelenein HR; Sourour SK; Fawzy IO; Salah S; Abdelaziz AI
Discov Med; 2015 Jun; 19(107):419-25. PubMed ID: 26175399
[TBL] [Abstract][Full Text] [Related]
36. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA
Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224
[TBL] [Abstract][Full Text] [Related]
37. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus.
Smith S; Gabhann JN; Higgs R; Stacey K; Wahren-Herlenius M; Espinosa A; Totaro MG; Sica A; Ball E; Bell A; Johnston J; Browne P; O'Neill L; Kearns G; Jefferies CA
Arthritis Rheum; 2012 May; 64(5):1601-9. PubMed ID: 22127978
[TBL] [Abstract][Full Text] [Related]
38. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
39. Identification of LncRNA Linc00513 Containing Lupus-Associated Genetic Variants as a Novel Regulator of Interferon Signaling Pathway.
Xue Z; Cui C; Liao Z; Xia S; Zhang P; Qin J; Guo Q; Chen S; Fu Q; Yin Z; Ye Z; Tang Y; Shen N
Front Immunol; 2018; 9():2967. PubMed ID: 30619325
[TBL] [Abstract][Full Text] [Related]
40. Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.
Rauch I; Rosebrock F; Hainzl E; Heider S; Majoros A; Wienerroither S; Strobl B; Stockinger S; Kenner L; Müller M; Decker T
Mol Cell Biol; 2015 Jul; 35(13):2332-43. PubMed ID: 25918247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
